Phase 4 Leukaemia Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Heart FailureChronic Lymphocytic Leukaemia
AstraZeneca60 enrolled23 locationsNCT06651970
Recruiting
Phase 4
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaLeukaemia (Acute)
Ain Shams University42 enrolled2 locationsNCT06918054
Not Yet Recruiting
Phase 4
Safety analysis of 90-minute Obinutuzumab infusion
Chronic Lymphocytic Leukaemia
Cairns Hospital128 enrolled1 locationACTRN12624001142527
Terminated
Phase 4
An Australian multicentre trial to compare the safety and efficacy of intravenous immunoglobulin replacement therapy with subcutaneous immunoglobulin replacement therapy (Hizentra®) to treat immunoglobulin deficiency in patients with chronic lymphocytic leukaemia (CLL)
Chronic Lymphocytic Leukaemia
Professor Stephen Mulligan90 enrolled3 locationsACTRN12617001008314